These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 18220748)

  • 21. Applications of influenza virosomes as a delivery system.
    Cusi MG
    Hum Vaccin; 2006; 2(1):1-7. PubMed ID: 17012895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virosomes for antigen and DNA delivery.
    Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
    Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.
    Moser C; Amacker M; Kammer AR; Rasi S; Westerfeld N; Zurbriggen R
    Expert Rev Vaccines; 2007 Oct; 6(5):711-21. PubMed ID: 17931152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The virosome concept for influenza vaccines.
    Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
    Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.
    Bungener L; Huckriede A; Wilschut J; Daemen T
    Biosci Rep; 2002 Apr; 22(2):323-38. PubMed ID: 12428908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccines: the virosome concept.
    Wilschut J
    Immunol Lett; 2009 Feb; 122(2):118-21. PubMed ID: 19100779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.
    Glück R; Metcalfe IC
    Vaccine; 2003 Jan; 21(7-8):611-5. PubMed ID: 12531327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applications of virosomes in cancer immunotherapy.
    Adamina M; Guller U; Bracci L; Heberer M; Spagnoli GC; Schumacher R
    Expert Opin Biol Ther; 2006 Nov; 6(11):1113-21. PubMed ID: 17049010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes.
    Westerfeld N; Pluschke G; Zurbriggen R
    Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):50-7. PubMed ID: 17131241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment.
    Liu H; Tu Z; Feng F; Shi H; Chen K; Xu X
    Acta Pharm; 2015 Jun; 65(2):105-16. PubMed ID: 26011928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza virosomes as vaccine adjuvant and carrier system.
    Moser C; Müller M; Kaeser MD; Weydemann U; Amacker M
    Expert Rev Vaccines; 2013 Jul; 12(7):779-91. PubMed ID: 23885823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Various carrier system(s)- mediated genetic vaccination strategies against malaria.
    Tyagi RK; Sharma PK; Vyas SP; Mehta A
    Expert Rev Vaccines; 2008 May; 7(4):499-520. PubMed ID: 18444895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virosome: An engineered virus for vaccine delivery.
    Ali H; Akbar M; Iqbal B; Ali F; Sharma NK; Kumar N; Najmi A; Albratty M; Alhazmi HA; Madkhali OA; Zoghebi K; Alam MS
    Saudi Pharm J; 2023 May; 31(5):752-764. PubMed ID: 37181145
    [No Abstract]   [Full Text] [Related]  

  • 34. Influenza virosomes as a vaccine adjuvant and carrier system.
    Moser C; Amacker M; Zurbriggen R
    Expert Rev Vaccines; 2011 Apr; 10(4):437-46. PubMed ID: 21506642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted gene delivery by virosomes.
    Sarkar DP; Ramani K; Tyagi SK
    Methods Mol Biol; 2002; 199():163-73. PubMed ID: 12094567
    [No Abstract]   [Full Text] [Related]  

  • 36. Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems.
    Wan Y; Moyle PM; Toth I
    Curr Med Chem; 2015; 22(29):3326-46. PubMed ID: 26303176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virosomal adjuvanted antigen delivery systems.
    Moser C; Metcalfe IC; Viret JF
    Expert Rev Vaccines; 2003 Apr; 2(2):189-96. PubMed ID: 12899570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery.
    Soltani F; Parhiz H; Mokhtarzadeh A; Ramezani M
    Curr Pharm Des; 2015; 21(42):6214-35. PubMed ID: 26503143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvements in gene therapy technologies.
    Kaneda Y
    Mol Urol; 2001; 5(2):85-9. PubMed ID: 11690554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.